Evidence map›Paper›PMID 31907057›Full record

ArticleJournal of biomedical science2020

Structural basis of polyethylene glycol recognition by antibody.

Cheng-Chung Lee, Yu-Cheng Su, Tzu-Ping Ko, Li-Ling Lin, Chih-Ya Yang, Stanley Shi-Chung Chang, Steve R Roffler, Andrew H-J Wang

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. PEG-mCherry interactions beyond classical macromolecular crowding.Protein science : a publication of the Protein Society · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Crystal structure of a three-tetrad, parallel, KActa crystallographica. Section F, Structural biology communications · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Cheng-Chung LeeInstitute of Biological Chemistry, Academia Sinica, Taipei, Taiwan. chengung@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0002-8259-4388
Yu-Cheng SuDepartment of Biological Science and Technology, National Chiao Tung University, Hsin-Chu, Taiwan.
Tzu-Ping KoInstitute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Li-Ling LinInstitute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Chih-Ya YangMedigen Biotechnology Corporation, Taipei, Taiwan.
Stanley Shi-Chung ChangMedigen Biotechnology Corporation, Taipei, Taiwan.
Steve R RofflerInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. sroff@ibms.sinica.edu.tw.
Andrew H-J WangInstitute of Biological Chemistry, Academia Sinica, Taipei, Taiwan. ahjwang@gate.sinica.edu.tw.
Institute of Biological Chemistry, Academia Sinica · TWInstitute of Biomedical Sciences, Academia Sinica · TWNational Taiwan University · TWNational Yang Ming Chiao Tung University · TW

Funding

Academia Sinica AS-SUMMIT-108Ministry of Science and Technology MOST 108-3114-Y-001-002Taiwan Protein Project AS-KPQ-105-TPPTechnology Supporting Platform Axis AS-KPQ-106-TSPA
6 · The paper itself

Abstract

backgroundPolyethylene glycol (PEG) is widely used in industry and medicine. Anti-PEG antibodies have been developed for characterizing PEGylated drugs and other applications. However, the underlying mechanism for specific PEG binding has not been elucidated.

methodsThe Fab of two cognate anti-PEG antibodies 3.3 and 2B5 were each crystallized in complex with PEG, and their structures were determined by X-ray diffraction. The PEG-Fab interactions in these two crystals were analyzed and compared with those in a PEG-containing crystal of an unrelated anti-hemagglutinin 32D6-Fab. The PEG-binding stoichiometry was examined by using analytical ultracentrifuge (AUC).

resultsA common PEG-binding mode to 3.3 and 2B5 is seen with an S-shaped core PEG fragment bound to two dyad-related Fab molecules. A nearby satellite binding site may accommodate parts of a longer PEG molecule. The core PEG fragment mainly interacts with the heavy-chain residues D31, W33, L102, Y103 and Y104, making extensive contacts with the aromatic side chains. At the center of each half-circle of the S-shaped PEG, a water molecule makes alternating hydrogen bonds to the ether oxygen atoms, in a similar configuration to that of a crown ether-bound lysine. Each satellite fragment is clamped between two arginine residues, R52 from the heavy chain and R29 from the light chain, and also interacts with several aromatic side chains. In contrast, the non-specifically bound PEG fragments in the 32D6-Fab crystal are located in the elbow region or at lattice contacts. The AUC data suggest that 3.3-Fab exists as a monomer in PEG-free solution but forms a dimer in the presence of PEG-550-MME, which is about the size of the S-shaped core PEG fragment.

conclusionsThe differing amino acids in 3.3 and 2B5 are not involved in PEG binding but engaged in dimer formation. In particular, the light-chain residue K53 of 2B5-Fab makes significant contacts with the other Fab in a dimer, whereas the corresponding N53 of 3.3-Fab does not. This difference in the protein-protein interaction between two Fab molecules in a dimer may explain the temperature dependence of 2B5 in PEG binding, as well as its inhibition by crown ether.

Indexed as

Antibody SpecificityBinding Sites, AntibodyAntibodies, Monoclonal, Murine-DerivedCrystallography, X-RayImmunoglobulin Fab FragmentsPolyethylene GlycolsAntibodies, Monoclonal, Murine-DerivedImmunoglobulin Fab FragmentsPolyethylene GlycolsCrown etherDimer formationPEG-fab complexProtein-protein interactionX-ray crystallography

Identifiers

PMID31907057
PMCPMC6945545
OpenAlexW3003030778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.